GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹12,449 Cr | ₹11,173 Cr | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr |
What is the latest Total Assets ratio of GLAND PHARMA ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹12,449 Cr |
| Mar2025 | ₹11,173 Cr |
| Mar2024 | ₹10,611 Cr |
| Mar2023 | ₹8,778 Cr |
| Mar2022 | ₹7,834 Cr |
How is Total Assets of GLAND PHARMA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,449 Cr | 11.42 | |
| Mar2025 | ₹11,173 Cr | 5.30 | |
| Mar2024 | ₹10,611 Cr | 20.89 | |
| Mar2023 | ₹8,778 Cr | 12.05 | |
| Mar2022 | ₹7,834 Cr | - | |
Compare Total Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹55,022.6 Cr | 6.7% | 9.2% | 75.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 6.7% |
9.2% |
75.8% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses